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sequences clustered within the Europe/
Turkey clade. The genetic distance be-
tween the 2 strains was 1.15%, but the 
2 sequences were identical at the amino 
acid level. Sequences from the present 
study showed 96.4%–98.8% similar-
ity with respective CCHFV sequences 
from Bulgaria from a former study 
(BUL10/02 and BUL1/03) (3) but 
differed from the Kosovo 9553/2001 
strain by 0.8%–2.0% and from the 
Greek 66/08 strain by 1.2%–2.4%.
Two additional suspected CCHF 
cases occurred in the same area, on 
March 30 and April 9 (7). Both per-
sons were negative for CCHFV infec-
tion. All 119 ticks of various species 
(Hyalomma marginatum, Dermacen-
tor marginatus, Rhipicephalus bursa, 
Ixodes ricinus) collected from the 
area and tested by reverse transcrip-
tion–nested PCR were negative for 
CCHFV.
This cluster of CCHF cases has 
several important highlights. First, it 
occurred in a region that was consid-
ered to have low CCHF endemicity; 
however, the area is only a few kilo-
meters from Greece, where a human 
fatal case was observed in June 2008 
(8). The index case was observed ear-
lier in the year than in previous years, 
and clinical manifestations of the 
cases were unusual (absence of cran-
iopharyngeal syndrome and bleeding 
from gastrointestinal tract that are 
typical for CCHF patients from Bul-
garia); in the fatal case, autopsy of the 
patient showed hemorrhages only in 
the lungs. Two cases were attributable 
to tick exposure, whereas the other 2 
were most likely secondary cases at-
tributable to contact with the index 
case-patient (in this regard, CCHFV 
sequences of the secondary cases were 
almost identical). Finally, the longer 
incubation period of the wife of the 
index case-patient might be associated 
with administration of hyperimmune 
gamma globulin against CCHFV.
In conclusion, CCHF emerged in 
southwestern Bulgaria near the border 
with Greece. Person-to-person trans-
mission emphasizes the need for rapid 
diagnosis of CCHF, especially in cases 
with atypical clinical manifestations.
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Wohlfahrtiimonas 
chitiniclastica  
Bacteremia in 
Homeless Woman
To the Editor: In May 2006, a 
60-year-old homeless woman with a 
history of alcoholism was admitted to 
the emergency department of the Con-
ception Hospital, Marseille, France. 
Firefighters had just found her in an 
abandoned container in the outskirts 
of the city, beside the body of her com-
panion, who had died several days ear-
lier. She described no symptoms other 
than fatigue. On examination, she was 
found to be dirty and covered with 
thousands of body and hair lice; doz-
ens of insect larvae were in her hair. 
She was mildly febrile (38°C) and had 
widespread excoriations but no sign 
of localized bacterial infection. Head 
shaving exposed superficial ulcers 
on her scalp but no maggots. Blood 
analysis showed marked neutropenia 
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(0.44 ×109/L), thrombocytopenia (28 
× 109/L), a marked but well-tolerated 
iron deficiency anemia (hemoglobin 
6.8g/dL), and a C-reactive protein 
level of 182 mg/L. Louse infestation 
was treated with a single dose of iver-
mectin (12 mg), and the woman was 
hospitalized. On day 3, she was still 
febrile. Louse-borne borreliosis had 
been ruled out by a negative blood 
smear, and results of serologic testing 
and molecular screening of lice for 
the other 2 louse-transmitted bacteria, 
Rickettsia prowazekii and Bartonella 
quintana (1), were negative.
In contrast, 2 cultures of blood 
taken at the time of admission grew 
gram-negative rods susceptible to 
amoxicillin, ceftriaxone, imipen-
em, ciprofloxacin, amikacin, and 
trimethoprim/sulfamethoxazole. How-
ever, phenotypic tests failed to identify 
this bacterium with accuracy. Intrave-
nous therapy with ceftriaxone at 2 g/d 
was initiated, and the patient’s fever, 
neutropenia, and thrombocytopenia 
improved. Scalp wounds healed with 
local care. Using 16S rRNA gene am-
plification and sequencing as previ-
ously described (2), we identified the 
bacilli as Wohlfahrtiimonas chitini-
clastica and determined its similarity 
to be 99.5% with strain E43 (Gen-
Bank accession no. AJ517825). The 
16S rRNA sequence obtained from 
the patient’s strain was deposited in 
GenBank under no. EU484335. The 
strain was deposited in the Collec-
tion de Souches de l’Unité des Rick-
ettsies (CSUR; World Data Center 
for Microorganisms 875, http://ifr48.
timone.univ-mrs.fr/portail2/index.
php?option = com_content&task = vi
ew&id = 96&Itemid = 52) under refer-
ence CSUR P16.
W. chitiniclastica is a recently 
described γ-proteobacterium isolated 
from larvae of the parasitic fly Wohl-
fahrtia magnifica (3). Although the 
pathogenicity of this new species for 
humans is as yet undescribed, it is phy-
logenetically close to Ignatzschineria 
larvae, another bacterium associated 
with W. magnifica larvae (4), which 
cause severe wound myiasis in cattle 
(5). Because of its strong chitinase 
activity, I. larvae may play a role in 
the metamorphosis of its host fly, as 
has been observed for other fly sym-
bionts, and thus may be a symbiont of 
W. magnifica flies (6). The bacterium 
was later discovered in swine waste 
in Quebec (7). In 2007, three publica-
tions renewed researchers’ interest in 
I. larvae. First it was reclassified as 
the only species within the genus Ig-
natzschineria (4). Then 2 case reports 
demonstrated that it plays a role as a 
human pathogen (8,9). Both described 
an I. larvae bacteremia in adults with 
myiasis in southeastern France. The 
first patient was an elderly farmer with 
diabetes and myiasis of the leg, scro-
tum, and anus (8). The second patient 
was a middle-aged homeless man with 
a history of alcoholism who also had 
foot wound myiasis (9).
We report W. chitiniclastica bac-
teremia also in a homeless woman 
from southeastern France. Although 
we did not test body lice for W. chitini-
clastica, we believe that the bactere-
mia originated from the patient’s scalp 
maggots. Unfortunately, as previously 
reported for cases of I. larvae bacte-
remia, the maggots had been rapidly 
discarded, permitting neither bacterial 
analysis nor entomologic identifica-
tion. However, these larvae may have 
been from W. magnifica flies. These 
flies are present in southern France, 
and although they are not typically 
found at low altitude and in a semiur-
ban environment, their distribution is 
known to be progressively expanding, 
in part because of their broad adapta-
tion capacities. Animal hosts for W. 
magnifica flies are numerous, but hu-
mans can also be infected; >10 cases 
of this myiasis in humans have been 
reported in Europe, Asia, Morocco, 
and Egypt. The scalp was affected in 
2 of these patients (10).
Among homeless persons, ec-
toparasitism is very common; body 
lice (Pediculus humanus humanus) 
are of particular interest because they 
transmit 3 bacterial bloodstream in-
fections: trench fever (B. quintana), 
epidemic typhus (R. prowazekii), and 
louse-borne relapsing fever (Borre-
lia recurrentis) (1). Myiasis should 
also be considered as a relevant type 
of ectoparasitism in homeless and 
hygiene-deficient persons. In addition, 
like body lice, ticks, and fleas, fly lar-
vae should also be regarded as another 
potential source of specific arthropod-
borne bacterial systemic infections.
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Serologic  
Screening for  
Neospora caninum, 
France
To the Editor: In the June 2008 
issue of Emerging Infectious Diseas-
es, McCann et al. (1) reported on sero-
logic screening for Neospora caninum 
antibodies and reported a lack of sero-
logic evidence for Neospora infection 
in humans in England, where preva-
lence of infection with the closely re-
lated parasite Toxoplasma gondii also 
is low. Only limited data are available 
on human exposure to Neospora. We 
investigated the seroprevalence of N. 
caninum in humans in France, where 
Toxoplasma spp. seroprevalence is 
high.
Our study comprised 500 serum 
samples from healthy women, fol-
lowed at the Cochin–Port Royal Uni-
versity Hospital in 1997 within the 
framework of toxoplasmosis surveil-
lance during pregnancy, and 400 serum 
samples from HIV-infected patients. 
All serum samples were submitted to 
anti-Toxoplasma antibody testing by 
using indirect immunofluorescence 
(IIF; Toxo-spot IFI; bioMérieux, 
Marcy l’Etoile, France) and ELISA 
(Platelia Toxo IgG and IgM; BioRad, 
Hercules, CA, USA). An in-house mi-
croplate IIF test previously validated 
in cattle was used for simultaneous 
detection of anti-Neospora and anti-
Toxoplasma immunoglobulin (Ig) G 
on the same microplate. All samples 
were screened at dilutions of 1:20 and 
1:80, as is usually done in anti-Toxo-
plasma IIF assays in humans. Corre-
lation between the anti-Toxoplasma 
IIF commercial test and in-house IIF 
was excellent (kappa coefficient = 
0.98) and allowed us to compare the 
antibody titers against both parasites. 
Forty (8%) samples from immuno-
competent persons and 21 (4%) from 
immunocompromised persons yielded 
a weak fluorescence when diluted 
1:20. All but 4 had significant titers of 
anti-Toxoplasma IgG (>200 IU/mL in 
77% of cases), which suggests low-
level cross-reactions. Whereas titers 
of >200 and >320 are considered suf-
ficient to diagnose neosporosis in dogs 
and cattle, respectively (2), positivity 
threshold was difficult to resolve in the 
absence of a positive human control. 
We decided on a positivity threshold 
of 1:80, which is similar to the thresh-
old defined by others in further studies 
using an indirect fluorescence anti-
body test in humans (3,4). None of the 
500 samples from immunocompetent 
persons were positive for Neospora 
antibodies when assessed at a dilution 
of 1:80. Within the group of immuno-
compromised persons, 3 were positive 
for Neospora antibodies at a titer of 
80, and 1 was positive at a titer of 160. 
Three of these 4 HIV-infected patients 
had high titers of anti-Toxoplasma IgG 
(>2,000 IU/mL), suggesting Toxoplas-
ma serologic reactivation. We found 
no evidence of Neospora infection or 
exposure in immunocompetent per-
sons but could not exclude possible 
Neospora infection associated with 
Toxoplasma infection or reactivation 
in immunocompromised persons.
Taken together, our data agree 
with data from other studies conduct-
ed in European countries (1,5), which 
suggest that neosporosis in healthy 
humans is unlikely. However, the 
Neospora spp. seropositivity of some 
HIV-infected patients, although weak 
compared with the level of seroposi-
tivity in cattle or dogs, could suggest 
circulation of the parasite within im-
munocompromised hosts, a hypoth-
esis supported by Lobato et al. (3). 
However, our observation of a strong 
serologic reactivation against T. gondii 
in 3 of 4 patients with anti-Neospora 
titers >80 mostly favors cross-reac-
tivity involving homologous antigens 
of both parasites and nonspecific an-
tibody binding from polyclonal stimu-
lation of the immune system. Finally, 
one should keep in mind that the posi-
tive predictive value of a serologic test 
used in screening in low-prevalence 
populations is low. Large-scale stud-
ies are needed to more precisely deter-
mine the potential role of this parasite 
in immunodeficient humans and to 
isolate the parasite or detect Neospora 
DNA in such patients.
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